Fountain Therapeutics is discovering and developing treatments for aging-associated diseases.
Fountain Therapeutics has raised $15.0M in total funding. The most recent round was Series A. The last funding was announced in November 2021.
Fountain Therapeutics's investors include Khosla Ventures, R42 Group, Alexandria Venture Investments, Nan Fung Life Sciences, Eli Lilly & Company Foundation.
Fountain Therapeutics is headquartered in San Francisco, United States.
Fountain Therapeutics is discovering and developing treatments for aging-associated diseases.
Fountain Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Fountain Therapeutics — Funding & Investors." VCBacked, November 18, 2021, https://www.vcbacked.co/company/fountain-therapeutics. Accessed October 3, 2026.
VCBacked. (2021). Fountain Therapeutics — Funding & Investors. Retrieved October 3, 2026, from https://www.vcbacked.co/company/fountain-therapeutics
{{cite web |title=Fountain Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/fountain-therapeutics |website=VCBacked |access-date=October 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated